The current stock price of HYPR is 0.9914 USD. In the past month the price decreased by -5.58%. In the past year, price increased by 5.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.29 | 219.41B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.95 | 207.41B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.35 | 145.84B | ||
| SYK | STRYKER CORP | 27.88 | 140.43B | ||
| BDX | BECTON DICKINSON AND CO | 14.23 | 58.56B | ||
| IDXX | IDEXX LABORATORIES INC | 56.49 | 56.88B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.91 | 49.08B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.21 | 40.16B | ||
| RMD | RESMED INC | 25.35 | 36.63B | ||
| DXCM | DEXCOM INC | 36.79 | 26.69B | ||
| PODD | INSULET CORP | 64.09 | 20.60B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.63 | 18.64B |
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 111 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
HYPERFINE INC
351 New Whitfield Street
Guilford CONNECTICUT US
Employees: 111
Phone: 18667966767
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 111 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
The current stock price of HYPR is 0.9914 USD. The price decreased by -0.86% in the last trading session.
HYPR does not pay a dividend.
HYPR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
8 analysts have analysed HYPR and the average price target is 1.68 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 0.9914.
HYPERFINE INC (HYPR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
HYPERFINE INC (HYPR) has a market capitalization of 96.33M USD. This makes HYPR a Micro Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to HYPR. While HYPR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months HYPR reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 10.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -96.49% | ||
| ROE | -149.05% | ||
| Debt/Equity | 0 |
8 analysts have analysed HYPR and the average price target is 1.68 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 0.9914.
For the next year, analysts expect an EPS growth of 17.13% and a revenue growth -1.92% for HYPR